STAT+: Pharmalittle: Pharma showers cash on a rising U.S. Senate star; FDA restricts use of a Glaxo Covid treatment

“I had this kind of naive view that if you start with the same cell every time, and you run the same process, every time, then you’re going to end… […]

PACT Pharma and UCLA researchers infused individualized cocktails of CRISPR-edited immune cells into 16 cancer patients with minimal and manageable side effects. […]

The “meaningful Eylea miss could potentially foreshadow biosimilar challenges,” an analyst said about Regeneron’s drug. […]